Salivary histamine level as a predictor of periodontal disease in type 2 diabetic and non-diabetic subjects.

BACKGROUND Some previous investigations underscored the role of histamine in periodontal disease, especially in diabetic patients, but the behavior of this inflammatory mediator in the early phases of periodontal involvement remains unclear. The aim of the present study was to correlate the presence of histamine in saliva with clinical parameters in healthy, periodontitis-affected, and diabetic subjects to ascertain whether this amine may serve as a predictive index of periodontal risk. METHODS For this purpose, subjects were selected as follows: 1) with newly diagnosed type 2 diabetes mellitus; 2) with neither diabetes nor periodontitis; 3) with no diabetes but with chronic, untreated periodontal disease. Histamine salivary levels were measured at the initial time (T0) and after 6, 12, and 24 months using high-performance liquid chromatography. The main periodontal indexes were recorded at the same time intervals. RESULTS At T0, a very typical shape of the histamine chromatogram was found for all patients of the three groups; at this time, the salivary histamine levels of diabetic patients were increased and comparable to those of healthy patients with periodontal disease, whereas healthy subjects with no periodontitis showed reduced histamine levels. Further controls at 6, 12, and 24 months showed a statistically significant correlation between the increase of salivary histamine and the worsening of the periodontal indexes in diabetic and non-diabetic subjects. CONCLUSION These results suggest that salivary histamine may serve as a predictive index in the prevention of periodontal disease.

[1]  I. Lamster,et al.  Gingival Crevicular Fluid Levels of Interleukin-1β and Glycemic Control in Patients With Chronic Periodontitis and Type 2 Diabetes , 2004 .

[2]  Y. Kiyohara,et al.  The Severity of Periodontal Disease is Associated with the Development of Glucose Intolerance in Non-diabetics: The Hisayama Study , 2004, Journal of dental research.

[3]  A. Somogyi,et al.  Diabetes and oral tumors in Hungary: epidemiological correlations. , 2004, Diabetes care.

[4]  J. Stewart,et al.  Periodontal disease and diabetes mellitus , 2004, Current diabetes reports.

[5]  Suchita Verma,et al.  Diabetes mellitus--a modifier of periodontal disease expression. , 2004, Journal of the International Academy of Periodontology.

[6]  P. Güneri,et al.  Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients. , 2004, Journal of periodontology.

[7]  E. Fıratlı,et al.  Gingival crevicular fluid levels of aspartate amino transferase, sulfide ions and N-benzoyl-DL-arginine-2-naphthylamide in diabetic patients with chronic periodontitis. , 2003, Journal of clinical periodontology.

[8]  J. J. Arrieta-Blanco,et al.  Dental problems in patients with diabetes mellitus (II): gingival index and periodontal disease. , 2003, Medicina oral : organo oficial de la Sociedad Espanola de Medicina Oral y de la Academia Iberoamericana de Patologia y Medicina Bucal.

[9]  I. B. Bender,et al.  Diabetes mellitus and the dental pulp. , 2003, Journal of endodontics.

[10]  B. Mealey,et al.  Periodontal disease and diabetes mellitus. Bidirectional relationship. , 2003, Dentistry today.

[11]  N. Gupta,et al.  Dentists, diabetes and periodontitis. , 2002, Australian dental journal.

[12]  R. Hashem,et al.  Effect of age receptor blocker and/or anti-inflammatory coadministration in relation to glycation, oxidative stress and cytokine production in stz diabetic rats. , 2002, Pharmacological research.

[13]  D. Matthews.  The relationship between diabetes and periodontal disease. , 2002, Journal.

[14]  R. MacIsaac,et al.  Diabetic ketoacidosis secondary to dento-alveolar infection. , 2002, International journal of oral and maxillofacial surgery.

[15]  R. Lalla,et al.  Dental management considerations for the patient with diabetes mellitus. , 2001, Journal of the American Dental Association.

[16]  T. Kislinger,et al.  Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.

[17]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[18]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[19]  T. Rees,et al.  Periodontal management of the patient with diabetes mellitus. , 2000, Periodontology 2000.

[20]  T. Kislinger,et al.  Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. , 2000, The Journal of clinical investigation.

[21]  F. Nishimura,et al.  Negative effects of chronic inflammatory periodontal disease on diabetes mellitus. , 2000, Journal of the International Academy of Periodontology.

[22]  P. Riederer,et al.  High molecular weight hyaluronic acid inhibits advanced glycation endproduct‐induced NF‐κB activation and cytokine expression , 1999 .

[23]  S. Offenbacher,et al.  Induction of prostaglandin release from macrophages by bacterial endotoxin. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  L. Niskanen,et al.  Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. , 1998, Journal of periodontology.

[25]  R. Arnold,et al.  Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. , 1997, Journal of periodontology.

[26]  J. Anderson,et al.  Periodontal status of diabetic and non-diabetic men: effects of smoking, glycemic control, and socioeconomic factors. , 1996, Journal of periodontology.

[27]  Grant Da.  Periodontal disease, diabetes, and immune response: a review of current concepts. , 1996 .

[28]  J. Pickup,et al.  Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[29]  J. Ainamo,et al.  A longitudinal study on insulin-dependent diabetes mellitus and periodontal disease. , 1993, Journal of clinical periodontology.

[30]  J. Selby,et al.  Epidemiology and Prevention of Periodontal Disease in Individuals With Diabetes , 1991, Diabetes Care.

[31]  P. Dandona,et al.  Histamine synthesis and catabolism in various tissues in diabetic rats. , 1990, Metabolism: clinical and experimental.

[32]  P. Dandona,et al.  Plasma histamine concentrations are elevated in patients with diabetes mellitus and peripheral vascular disease. , 1989, Metabolism: clinical and experimental.

[33]  P. Dandona,et al.  Increased histamine in plasma and tissues in diabetic rats. , 1988, Diabetes research (Edinburgh, Scotland).

[34]  T. Hyyppa.  Gingival IgE and histamine concentrations in patients with asthma and in patients with periodontitis , 1984 .

[35]  T. Hyyppa.  Studies on immunologic and inflammatory factors in saliva in patients with asthma and in patients with periodontitis , 1981 .

[36]  R. Genco,et al.  Neutrophil chemotaxis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. , 1981, Journal of periodontology.

[37]  J. Wennström,et al.  The mechanism of basophil histamine release in patients with periodontal disease. , 1978, Clinical and experimental immunology.

[38]  M. Grujic,et al.  [Dental and oral aspects of diabetes mellitus]. , 1977, Stomatoloski glasnik Srbije.

[39]  A Mowat,et al.  Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. , 1971, The New England journal of medicine.

[40]  H. Löe,et al.  PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY. , 1963, Acta odontologica Scandinavica.